journal
Journals Molecular Genetics & Genomic M...

Molecular Genetics & Genomic Medicine

https://read.qxmd.com/read/38451012/abcg2-polymorphisms-and-susceptibility-to-arv-associated-hepatotoxicity
#1
JOURNAL ARTICLE
HariOm Singh, Kishore Dhotre, Shyamveer, Ranjana Choudhari, Amita Verma, Supriya D Mahajan, Nemat Ali
BACKGROUND: The ABCG2 421C/A polymorphism contributes significantly to the distribution and absorption of antiretroviral (ARV) regimens and is associated with the undesirable side effects of efavirenz. METHODS: To investigate this, we examined ABCG2 34G/A (rs2231137) and 421C/A (rs2231142) genetic variations in 149 HIV-infected patients (116 without hepatotoxicity, 33 with ARV-induced hepatotoxicity) and 151 healthy controls through the PCR-restriction fragment length polymorphism (PCR-RFLP) technique...
March 7, 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38419387/a-novel-frameshift-mutation-in-sox10-gene-induced-waardenburg-syndrome-type-ii
#2
JOURNAL ARTICLE
Xiuli Ma, Liping Zhao, Li Li, Xia Li, Chaohong Ding, Jing Ma
OBJECTIVE: To explore the molecular etiology of Waardenburg syndrome type II (WS2) in a family from Yunnan province, China. METHODS: A total of 406 genes related to hereditary hearing loss were sequenced using next-generation sequencing. DNA samples were isolated from the peripheral blood DNA of probands. Those pathogenic mutations detected by next-generation sequencing in probands and their parents were validated by Sanger sequencing. The conservatism of variation sites in genes was also analyzed...
February 28, 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38366804/hope-but-never-expect-comparing-parents-pre-and-post-disclosure-attitudes-toward-return-of-results-from-diagnostic-exome-sequencing-for-their-child
#3
JOURNAL ARTICLE
Candice Cornelis, Aad Tibben, Eva Brilstra, Ineke Bolt, Marieke van Summeren, Nine Knoers, Annelien L Bredenoord
BACKGROUND: Counseling for whole-exome sequencing (WES) could benefit from aligning parents' pre- and post-disclosure attitudes. A few studies have qualitatively compared parents' pre- and post-disclosure attitudes toward receiving WES results for their child in a diagnostic setting. This study explored these attitudes in the context of children with a developmental delay. METHODS: Semi-structured interviews were conducted with parents (n = 27) of 16 children undergoing diagnostic WES in trio-analysis, both before and after receiving results...
February 17, 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38265426/identification-of-a-complex-intrachromosomal-inverted-insertion-in-the-long-arm-of-chromosome-9-as-a-cause-of-tuberous-sclerosis-complex-in-a-korean-family
#4
JOURNAL ARTICLE
Seung Woo Ryu, Ji-Hee Yoon, Dong-Wook Kim, Beomman Han, Heonjong Han, Joohyun Han, Hane Lee, Go Hun Seo, Beom Hee Lee
BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder, caused by a loss-of-function of either TSC1 or TSC2 gene. However, in 10%-15% TSC patients there is no pathogenic variant identified in either TSC1 or TSC2 genes based on standard clinical testing. METHODS: In this study, genome sequencing was performed for families with clinical diagnosis of TSC with negative results from TSC1 and TSC2 single-gene tests. RESULTS: Herein, we report a family presenting a classical TSC phenotype with an unusual, complex structural variant involving the TSC1 gene: an intrachromosomal inverted insertion in the long arm of chromosome 9...
January 24, 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38263869/clinically-significant-findings-in-a-decade-long-retrospective-study-of-prenatal-chromosomal-microarray-testing
#5
JOURNAL ARTICLE
Joie O Olayiwola, Mohammad Marhabaie, Daniel Koboldt, Theodora Matthews, Amy Siemon, Danielle Mouhlas, Taylor Porter, George Kyle, Cortlandt Myers, Hui Mei, Ying-Chen Claire Hou, Melanie Babcock, Jesse Hunter, Kathleen M Schieffer, Yassmine Akkari, Shalini Reshmi, Catherine Cottrell, Mariam T Mathew, Marco L Leung
BACKGROUND: Chromosomal microarray (CMA) is commonly utilized in the obstetrics setting. CMA is recommended when one or more fetal structural abnormalities is identified. CMA is also commonly used to determine genetic etiologies for miscarriages, fetal demise, and confirming positive prenatal cell-free DNA screening results. METHODS: In this study, we retrospectively examined 523 prenatal and 319 products-of-conception (POC) CMA cases tested at Nationwide Children's Hospital from 2011 to 2020...
January 23, 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38618971/rars1-related-hypomyelinating-leukodystrophy-9-hld-9-in-two-distinct-iranian-families-case-report-and-literature-review
#6
REVIEW
Sajjad Biglari, Hassan Vahidnezhad, Mohammad Amin Tabatabaiefar, Hamid Reza Khorram Khorshid, Emran Esmaeilzadeh
BACKGROUND: Hypomyelinating leukodystrophy-9 (HLD-9) is caused by biallelic pathogenic variants in RARS1, which codes for the cytoplasmic tRNA synthetase for arginine (ArgRS). This study aims to evaluate the clinical, neuroradiological, and genetic characteristics of patients with RARS1-related disease and determine probable genotype-phenotype relationships. METHODS: We identified three patients with RARS1 homozygous pathogenic variants. Furthermore, we performed a comprehensive review of the literature...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38618928/auriculocondylar-syndrome-2-caused-by-a-novel-plcb4-variant-in-a-male-chinese-neonate-a-case-report-and-review-of-the-literature
#7
JOURNAL ARTICLE
Yongli Zhang, Yuwei Zhao, Liying Dai, Yu Liu, Zifeng Shi
BACKGROUND: Auriculocondylar syndrome (ARCND) is a rare congenital craniofacial developmental malformation syndrome of the first and second pharyngeal arches with external ear malformation at the junction between the lobe and helix, micromaxillary malformation, and mandibular condylar hypoplasia. Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38613222/genotype-and-phenotype-in-patients-with-acan-gene-variants-three-cases-and-literature-review
#8
JOURNAL ARTICLE
Wei Tang, Ke-Mi Wu, Qiong Zhou, Yan-Fei Tang, Jun-Fen Fu, Guan-Ping Dong, Chao-Chun Zou
OBJECTIVE: To characterize the phenotype spectrum, diagnosis, and response to growth-promoting therapy in patients with ACAN variants causing familial short stature. METHODS: Three families with ACAN variants causing short stature were reported. Similar cases in the literature were summarized, and the genotype and phenotype were analyzed. RESULTS: Three novel heterozygous variants, c.757+1G>A, (splicing), c.6229delG, p.(Asp2078Tfs*1), and c...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38591167/further-delineation-of-phenotype-and-genotype-of-kenny-caffey-syndrome-type-2-phenotype-and-genotype-of-kcs-type-2
#9
REVIEW
Xuefei Chen, Chaochun Zou
BACKGROUND: Kenny-Caffey syndrome type 2 (KCS2) is an extremely rare inherited disorder characterized by proportionate short stature, skeletal defects, ocular and dental abnormalities, and transient hypocalcemia. It is caused by variants in FAM111A gene. Diagnosis of KCS2 can be challenging because of its similarities to other syndromes, the absence of clear hallmarks and the deficient number of genetically confirmed cases. Here, we aimed to further delineate and summarize the genotype and phenotype of KCS2, in order to get a better understanding of this rare disorder, and promote early diagnosis and intervention...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38588252/the-clinical-value-of-optical-genome-mapping-in-the-rapid-characterization-of-rb1-duplication-and-15q23q24-2-triplication-for-more-appropriate-prenatal-genetic-counselling
#10
JOURNAL ARTICLE
Malek Bouassida, Denise Molina-Gomes, Fairouz Koraichi, Bérénice Hervé, Morgane Lhuilier, Clémence Duvillier, Jessica Le Gall, Marion Gauthier-Villars, Valérie Serazin, Thibaud Quibel, Rodolphe Dard, François Vialard
BACKGROUND: Despite recent advances in prenatal genetic diagnosis, medical geneticists still face considerable difficulty in interpreting the clinical outcome of copy-number-variant duplications and defining the mechanisms underlying the formation of certain chromosomal rearrangements. Optical genome mapping (OGM) is an emerging cytogenomic tool with proved ability to identify the full spectrum of cytogenetic aberrations. METHODS: Here, we report on the use of OGM in a prenatal diagnosis setting...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38588043/a-case-of-polyglucosan-body-myopathy-caused-by-an-rbck1-gene-variant-and-literature-review
#11
JOURNAL ARTICLE
Qiqing Sun, Zhenhua Xie, Lifang Song, Dapeng Fu
OBJECTIVE: To analyze the clinical and genetic characteristics of a patient with Polyglucosan body myopathy 1 (PGBM1) caused by a novel compound heterozygous variant in the RBCK1 gene. METHODS: The clinical data of the patient were collected, next-generation sequencing technology was used to determine the exome sequence of the patient, and the suspected pathogenic locus was verified by Sanger sequencing. RESULTS: Through whole-exome sequencing, we found that there were c...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38581124/autism-spectrum-disorder-profiles-in-rasopathies-a%C3%A2-systematic-review
#12
REVIEW
Edward Debbaut, Jean Steyaert, Mouna El Bakkali
BACKGROUND: RASopathies are associated with an increased risk of autism spectrum disorder (ASD). For neurofibromatosis type 1 (NF1) there is ample evidence for this increased risk, while for other RASopathies this association has been studied less. No specific ASD profile has been delineated so far for RASopathies or a specific RASopathy individually. METHODS: We conducted a systematic review to investigate whether a specific RASopathy is associated with a specific ASD profile, or if RASopathies altogether have a distinct ASD profile compared to idiopathic ASD (iASD)...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38581121/clinical-and-genetic-characteristics-of-three-patients-with-congenital-insensitivity-to-pain-with-anhidrosis-case-reports-and-a-review-of-the-literature
#13
JOURNAL ARTICLE
Jun Hee Cho, Soojin Hwang, Yoon Hae Kwak, Mi-Sun Yum, Go Hun Seo, June-Young Koh, Young Seok Ju, Ji-Hee Yoon, Minji Kang, Hyo-Sang Do, Soyoung Kim, Gu-Hwan Kim, Hyunwoo Bae, Beom Hee Lee
BACKGROUND: Congenital insensitivity to pain with anhidrosis (CIPA) is an extremely rare autosomal recessive disorder caused by loss-of-function mutations of the NTRK1 gene, affecting the autonomic and sensory nervous system. Clinical manifestation is varied and includes recurrent fever, pain insensitivity, anhidrosis, self-mutilating behavior, and intellectual disability. METHODS: Clinical and genetic features were assessed in two males and one female with genetically confirmed CIPA using exome or genome sequencing...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38572916/identification-and-validation-of-a-novel-anoikis-related-prognostic-model-for-prostate-cancer
#14
JOURNAL ARTICLE
Peipei Zhang, Wenzhi Lv, Yang Luan, Wei Cai, Xiangde Min, Zhaoyan Feng
BACKGROUND: Anoikis resistance is a hallmark characteristic of oncogenic transformation, which is crucial for tumor progression and metastasis. The aim of this study was to identify and validate a novel anoikis-related prognostic model for prostate cancer (PCa). METHODS: We collected a gene expression profile, single nucleotide polymorphism mutation and copy number variation (CNV) data of 495 PCa patients from the TCGA database and 140 PCa samples from the MSKCC dataset...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38562051/clinical-application-value-of-pre-pregnancy-carrier-screening-in-chinese-han-childbearing-population
#15
JOURNAL ARTICLE
Li Tan, Yuefan Qi, Peijuan Zhao, LanLan Cheng, Guo Yu, Dongmei Zhao, Yu Xia Song, Yun Gai Xiang
BACKGROUND: To explore the clinical application value of pre-conception expanded carrier screening (PECS) in the Chinese Han ethnicity population of childbearing age. METHODS: The results of genetic testing of infertile parents who underwent PECS in the Reproductive Medicine Center of the Second Affiliated Hospital of Zhengzhou University, China, from September 2019 to December 2021, were retrospectively analyzed. The carrier rate of single gene disease, the detection rate of high-risk parents, and the clinical outcome of high-risk parents were statistically analyzed...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38562046/atypical-mandibulofacial-dysostosis-with-microcephaly-diagnosed-through-the-identification-of-a-novel-pathogenic-mutation-in-eftud2
#16
JOURNAL ARTICLE
Ying Chen, Run Yang, Xin Chen, Naier Lin, Chenlong Li, Yaoyao Fu, Aijuan He, Yimin Wang, Tianyu Zhang, Jing Ma
BACKGROUND: Mandibulofacial dysostosis with microcephaly (MFDM, OMIM# 610536) is a rare monogenic disease that is caused by a mutation in the elongation factor Tu GTP binding domain containing 2 gene (EFTUD2, OMIM* 603892). It is characterized by mandibulofacial dysplasia, microcephaly, malformed ears, cleft palate, growth and intellectual disability. MFDM can be easily misdiagnosed due to its phenotypic overlap with other craniofacial dysostosis syndromes. The clinical presentation of MFDM is highly variable among patients...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38553934/initial-clinical-and-molecular-investigation-of-20q13-33-microdeletion-with-17q25-3-14q32-31q32-33-microduplication-in-chinese-pediatric-patients
#17
JOURNAL ARTICLE
Jianlong Zhuang, Na Zhang, Junyu Wang, Yuying Jiang, Hegan Zhang, Chunnuan Chen
BACKGROUND: Limited research has been conducted regarding the elucidation of genotype-phenotype correlations within the 20q13.33 region. The genotype-phenotype association of 20q13.33 microdeletion remains inadequately understood. In the present study, two novel cases of 20q13.33 microdeletion were introduced, with the objective of enhancing understanding of the genotype-phenotype relationship. METHODS: Two unrelated patients with various abnormal clinical phenotypes from Fujian province Southeast China were enrolled in the present study...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38553911/rapid-and-long-lasting-efficacy-of-high-dose-ambroxol-therapy-for-neuronopathic-gaucher-disease-a-case-report-and-literature-review
#18
REVIEW
Kanako Higashi, Yuri Sonoda, Noriyuki Kaku, Fumihiko Fujii, Fumiya Yamashita, Sooyoung Lee, Vlad Tocan, Go Ebihara, Wakato Matsuoka, Kenichi Tetsuhara, Motoshi Sonoda, Pin Fee Chong, Yuichi Mushimoto, Kanako Kojima-Ishii, Masataka Ishimura, Yuhki Koga, Atsuhisa Fukuta, Nana Akagi Tsuchihashi, Yoshikazu Kikuchi, Takahito Karashima, Takaaki Sawada, Taeko Hotta, Makoto Yoshimitsu, Hideyuki Terazono, Tatsuro Tajiri, Takashi Nakagawa, Yasunari Sakai, Kimitoshi Nakamura, Shouichi Ohga
Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1-encoded enzyme, β-glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD). High-dose ambroxol has been administered as an alternative treatment for a group of patients with nGD. However, little is known about the clinical indication and the long-term outcome of patients after ambroxol therapy. We herein report a case of a female patient who presented with a progressive disease of GD type 2 from 11 months of age and had the pathogenic variants of p...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38546112/a-novel-variant-in-asns-gene-responsible-for-syndromic-intellectual-disability-and-microcephaly-case-report-and-literature-review
#19
JOURNAL ARTICLE
Mohammad Jahanpanah, Diana Mokhtari, Haleh Mokaber, Sara Arish, Farzad Ahmadabadi, Behzad Davarnia
BACKGROUND: The ASNS (ASNS, MIM 108370) gene variations are responsible for asparagine synthetase deficiency (ASNSD, MIM 615574), a very rare autosomal recessive disease characterized by cerebral anomalies. These patients have congenital microcephaly, progressive encephalopathy, severe intellectual disability, and intractable seizures. METHOD: Clinical characteristics of the patient were collected. Exome sequencing was used for the identification of variants. Sanger sequencing was used to confirm the variant in the target region...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38546032/phosphoserine-aminotransferase-deficiency-diagnosed-by-whole-exome-sequencing-and-lc-ms-ms-reanalysis-a-case-report-and-review-of-literature
#20
REVIEW
Jiaci Li, Xinping Wei, Yuchen Sun, Xiaofang Chen, Ying Zhang, Xiaoyu Cui, Jianbo Shu, Dong Li, Chunquan Cai
BACKGROUND: Phosphoserine aminotransferase deficiency (PSATD) is an autosomal recessive disorder associated with hypertonia, psychomotor retardation, and acquired microcephaly. Patients with PSATD have low concentrations of serine in plasma and cerebrospinal fluid. METHODS: We reported a 2-year-old female child with developmental delay, dyskinesia, and microcephaly. LC-MS/MS was used to detect amino acid concentration in the blood and whole-exome sequencing (WES) was used to identify the variants...
April 2024: Molecular Genetics & Genomic Medicine
journal
journal
48191
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.